One may speculate that interference with CCR8+ tumor Treg cells could not only reduce suppression of anti-tumor immunity but also impair tumor repair mechanisms, which is another potentially beneficial effect of CCR8-targeted immunotherapy. The gene discussed is CCR8; the disease is neoplasm.